http://www.fiercebiotech.com/press-releases/researchers-proceed-develop-...

Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.

The findings appear in the March 1 issue of the Journal of Immunology, a leading scientific journal in the field of immunology.

The cause of Parkinson's disease is the loss of neurons which produce dopamine, a nerve signaling chemical that controls movement and balance. The Parkinson's Disease Foundation estimates that about 1 million people in the United States and more than 4 million people worldwide have the disease.

Degeneration and loss of these dopamine-producing neurons typically occur after age 60, and it is estimated that one person in 20 over the age of 80 has Parkinson's.

Read more: http://www.fiercebiotech.com/press-releases/researchers-proceed-develop-...